Why COVID-19 patients lose their sense of smell

Why COVID-19 patients lose their sense of smell has been a mystery — until now. It has to do with how the virus attacks the nose.

Researchers have identified the cells in the nose that are most susceptible to infection by SARS-CoV-2, the virus that causes COVID-19. It turns out, they’re important for smelling. 

Anosmia, having no sense of smell, is one of the most widely named and unique COVID-19 symptoms — even predicting the disease earlier than other common symptoms, like cough, fever, or trouble breathing.

People infected with the novel coronavirus don’t lose their ability to smell because of a flu-like stuffy nose — the trouble affects even those with clear nasal passages. Why exactly so many do lose their sense of smell has been unclear — until now.

Oddly, the neurons that detect smells and communicate them to the brain are not the virus’s targets — structural nose tissues are. This invasion kicks off a domino chain-reaction, as cells self-destruct to stop the virus.

“Our findings indicate that the novel coronavirus changes the sense of smell in patients not by directly infecting neurons but by affecting the function of supporting cells,” said Sandeep Robert Datta, a neurobiologist at Harvard Medical School.

The novel coronavirus is thought to enter human cells through a protein common on the surface of heart, lung, and nasal cells. That protein is an enzyme called angiotensin-converting enzyme II, or ACE-2, which helps to regulate blood pressure.

Unfortunately, ACE-2 also fits like a puzzle with the spike protein on the novel coronavirus.

Reporting in Science Advances, a team of researchers led by Harvard Medical School neuroscientists looked at tissue cells inside the nose, counting up the ACE-2 protein. They found that the ACE-2 protein was 200-700 times more abundant in tissues in the back of the nose, which are associated with smell, than in other areas.

“These olfactory supporting cells are necessary to protect and maintain the delicate neurons in the nose that detect odors and signal that information to the brain,” neurologist Andrew Lane told Science Focus.

“Generally speaking, when cells are infected with a virus, they undergo a process called pyroptosis — essentially hitting the self-destruct button to foil the virus. So, most likely, olfactory supporting cells destroy themselves, leading in turn to the death of sensory neurons and loss of the  sense of smell.”

The sense of smell returns after some time for most COVID-19 patients, but a few are left with parosmia, an abnormal sense of smell. Lane says this warrants further study before researchers can say if this is a permanent condition.

This newly found connection between nose tissue cells and COVID-19 could lead to new treatment options directly via the nose.

We’d love to hear from you! If you have a comment about this article or if you have a tip for a future Freethink story, please email us at [email protected].

What’s next for COVID-19 drugs?
Paxlovid may have underperformed in a new trial, but other promising COVID-19 drugs are being authorized or in the works.
New antiviral shortens COVID-19 by 1.5 days
People taking simnotrelvir, a new antiviral treatment for COVID-19, felt almost immediate symptom relief and got better 1.5 days faster.
World’s first “self-amplifying” vaccine approved in Japan
The approval of the first saRNA vaccine could signal a new era in how we prevent and treat everything from infections to cancer.
HIV drug shows promise against COVID-19 and MERS
Based on promising lab tests, the HIV drug cobicistat could be an effective antiviral treatment for COVID-19.
How AI played an instrumental role in making mRNA vaccines
Years before Moderna created an effective mRNA vaccine against COVID, the company put into place AI systems to accelerate the research process.
Up Next
Subscribe to Freethink for more great stories